Your browser doesn't support javascript.
loading
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.
Chandran, Smita S; Ma, Jiaqi; Klatt, Martin G; Dündar, Friederike; Bandlamudi, Chaitanya; Razavi, Pedram; Wen, Hannah Y; Weigelt, Britta; Zumbo, Paul; Fu, Si Ning; Banks, Lauren B; Yi, Fei; Vercher, Enric; Etxeberria, Inaki; Bestman, Watchain D; Da Cruz Paula, Arnaud; Aricescu, Ilinca S; Drilon, Alexander; Betel, Doron; Scheinberg, David A; Baker, Brian M; Klebanoff, Christopher A.
Afiliação
  • Chandran SS; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandrs1@mskcc.org.
  • Ma J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandrs1@mskcc.org.
  • Klatt MG; Parker Institute for Cancer Immunotherapy, New York, NY, USA. chandrs1@mskcc.org.
  • Dündar F; Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, IN, USA.
  • Bandlamudi C; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
  • Razavi P; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wen HY; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Weigelt B; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
  • Zumbo P; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Fu SN; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Banks LB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yi F; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Vercher E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Etxeberria I; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bestman WD; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Da Cruz Paula A; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
  • Aricescu IS; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Drilon A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Betel D; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Scheinberg DA; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Baker BM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Klebanoff CA; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Med ; 28(5): 946-957, 2022 05.
Article em En | MEDLINE | ID: mdl-35484264
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Neoplasias / Neoplasias Limite: Animals / Humans Idioma: En Revista: Nat Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Neoplasias / Neoplasias Limite: Animals / Humans Idioma: En Revista: Nat Med Ano de publicação: 2022 Tipo de documento: Article